Inomed (Inosine Pranobex)

Inosine Pranobex stimulates T‑lymphocyte activity and boosts interferon‑alpha production, which together strengthen the body’s antiviral defenses. It also interferes with viral replication mechanisms, offering a dual action of immune modulation and direct antiviral effect against a broad range of viruses.

The dosage of Inomed is individualized by the prescribing clinician based on the specific indication, patient age, weight, renal and hepatic function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Inomed in pregnancy and lactation are limited. It should be used only if the potential therapeutic benefit justifies any possible risk to the fetus or infant. Healthcare providers will evaluate the risk‑benefit profile before prescribing to pregnant or nursing individuals.

To place an order, submit an enquiry on the Inomed product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with conventional antivirals that target specific viral enzymes, Inomed offers a broader immunomodulatory approach by enhancing host immune responses while also exerting direct antiviral activity. This dual mechanism can be advantageous in infections where immune support is beneficial, though choice of therapy depends on the specific virus, disease severity, and patient factors.

Inomed should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s stability and potency throughout its shelf life.

Inomed is taken orally, usually with water. The exact administration schedule, such as frequency and duration, is determined by the prescribing clinician based on the indication and patient-specific considerations.

Serious adverse reactions, though rare, can include severe hypersensitivity (anaphylaxis), significant liver injury, hematologic abnormalities like leukopenia or thrombocytopenia, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms such as rash, difficulty breathing, jaundice, unexplained bruising, or palpitations.

Inomed is contraindicated in individuals with known hypersensitivity to Inosine Pranobex or any excipients in the formulation. Caution is also advised for patients with severe hepatic or renal impairment, uncontrolled autoimmune disorders, or those receiving live vaccines, unless a healthcare professional determines the benefits outweigh the risks.